ID: ALA269619

Max Phase: Preclinical

Molecular Formula: C15H15N3O2

Molecular Weight: 269.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)CCn1cc(Cn2ccnc2)c2ccccc21

Standard InChI:  InChI=1S/C15H15N3O2/c19-15(20)5-7-18-10-12(9-17-8-6-16-11-17)13-3-1-2-4-14(13)18/h1-4,6,8,10-11H,5,7,9H2,(H,19,20)

Standard InChI Key:  OYFYHWCPIXGZGF-UHFFFAOYSA-N

Associated Targets(Human)

Thromboxane-A synthase 3355 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Prostaglandin I2 synthase 104 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Prostaglandin G/H synthase (cyclooxygenase) 160 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cytochrome P450 11B1 49 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 269.30Molecular Weight (Monoisotopic): 269.1164AlogP: 2.36#Rotatable Bonds: 5
Polar Surface Area: 60.05Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.37CX Basic pKa: 6.46CX LogP: 1.08CX LogD: 0.06
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.77Np Likeness Score: -1.54

References

1. Cross PE, Dickinson RP, Parry MJ, Randall MJ..  (1986)  Selective thromboxane synthetase inhibitors. 2. 3-(1H-imidazol-1-ylmethyl)-2-methyl-1H-indole-1-propanoic acid and analogues.,  29  (3): [PMID:3081722] [10.1021/jm00153a007]

Source